Cash Flow StemCell Institute Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
217.00
565.00
441.00
278.00
212.00
91.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-115.00
57.00
-93.00
-195.00
136.00
238.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
73.00
467.00
334.00
99.00
469.00
238.00
Cash Flow from Investing Activities
-337.00
-259.00
-811.00
-285.00
404.00
-520.00
Cash Flow from Financing Activities
-175.00
146.00
-1.00
0.00
644.00
0.00
Net Cash Inflow / Outflow
-404.00
355.00
-478.00
-186.00
1,517.00
-281.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
35.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of StemCell Institute
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
217.786
-297.194
514.00
173.28%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-115.66
-192.543
77.00
39.93%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
73.509
-432.477
505.00
117.00%
Cash Flow from Investing Activities
-337.92
-19.97
-318.00
-1592.14%
Cash Flow from Financing Activities
-175.087
3.665
-178.00
-4877.27%
Net Cash Inflow / Outflow
-404.324
-448.782
44.00
9.91%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
35.174
0
35.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -84.28% vs 39.76% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
73.51
467.69
-84.28%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
